GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $3.13 million. The enterprise value is -$5.71 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 477,381 shares outstanding.
| Current Share Class | 477,381 |
| Shares Outstanding | 477,381 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 43.01% |
| Owned by Institutions (%) | 91.80% |
| Float | 428,233 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.85 |
| Quick Ratio | 4.67 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.04 |
Financial Efficiency
Return on equity (ROE) is -694.34% and return on invested capital (ROIC) is -230.99%.
| Return on Equity (ROE) | -694.34% |
| Return on Assets (ROA) | -161.01% |
| Return on Invested Capital (ROIC) | -230.99% |
| Return on Capital Employed (ROCE) | -197.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.41M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.73% in the last 52 weeks. The beta is -0.19, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -99.73% |
| 50-Day Moving Average | 8.47 |
| 200-Day Moving Average | 670.89 |
| Relative Strength Index (RSI) | 44.28 |
| Average Volume (20 Days) | 1,596,954 |
Short Selling Information
| Short Interest | 1.47M |
| Short Previous Month | 596,332 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.09M |
| Pretax Income | -7.56M |
| Net Income | -26.50M |
| EBITDA | -15.05M |
| EBIT | -15.09M |
| Earnings Per Share (EPS) | -$566.30 |
Full Income StatementBalance Sheet
The company has $9.10 million in cash and $262,000 in debt, giving a net cash position of $8.84 million or $18.51 per share.
| Cash & Cash Equivalents | 9.10M |
| Total Debt | 262,000 |
| Net Cash | 8.84M |
| Net Cash Per Share | $18.51 |
| Equity (Book Value) | 7.26M |
| Book Value Per Share | 17.02 |
| Working Capital | 7.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.49 million and capital expenditures -$54,000, giving a free cash flow of -$12.54 million.
| Operating Cash Flow | -12.49M |
| Capital Expenditures | -54,000 |
| Free Cash Flow | -12.54M |
| FCF Per Share | -$26.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
